Bio-artificial organs and bio-engineered or bio-printed tissues for transplantation in humans are rapidly being developed. It is anticipated that some applications will be ready for clinical testing in the near future. How can first-in-human clinical trials be conducted in a safe and responsible manner? What are ethical points to consider for early clinical trials of regenerative medicine in transplantation?
To discuss these and related topics, our partner Erasmus MC organised a VANGUARD workshop titled Ethics of early clinical trials in regenerative medicine in transplantation in February 2022. This workshop brought together 74 participants and experts in the fields of regenerative medicine and ethics to discuss these ethical challenges. The video below shows the full recording of the VANGUARD Ethics workshop held online, Thursday 3 February 2022 from 16:00-18:00.